Prevention and control of non-communicable diseases in iran: the case for Investment

• Egile Nagusiak: Mahmood Yousefi (Egilea), Ilker Dastan (Egilea), Farbod Alinezhad (Egilea), Mansour Ranjbar (Egilea), Christoph Hamelmann (Egilea), Afshin Ostovar (Egilea), Alireza Moghisi (Egilea), Sima Mohammadi (Egilea), Awad Mataria (Egilea), Asmus Hammerich (Egilea), Slim Slama (Egilea), Nasim Pourghazian (Egilea), Alireza Mahdavi Hezaveh (Egilea), Behzad Valizadeh (Egilea), Parisa Torabi (Egilea), Mehdi Najmi (Egilea), Mohammad Moradi (Egilea), Alieh Hodjatzadeh (Egilea), Fatemeh Keshvari-Shad (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2022-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Non-communicable diseases are imposing a considerable burden on Iran. This study aims to assess the Return on Investment (ROI) for implementation of Non-communicable diseases (NCDs) prevention program in Iran. Methods Four disease groups including cardiovascular diseases, diabete...